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1. Introduction
Mitral regurgitation (MR) 
remains the second dominant 
defect in the structure of valvular 
cardiac diseases [1]. 
It affects more than 2 mil-
lion people in the USA. Basic 
causes are classified as degener-
ative (with valve prolapse) and 
ischemic (due to ischemic heart 
disease) in advanced countries 
or rheumatic ones (in developing 
countries) [2, 3].
Annual mortality of the pa-
tients aged more than 50 who re-
ceive only drug therapy is around 
3 % for moderate MR and over 
6 % for severe organic MR [2]. 
Alone radical method of MR 
treatment is surgical correc-
tion through mitral valve repair 
(MVRe) or replacement (MVR) 
yielding definitely higher surviv-
al percentage and improvement 
of heart failure (HF) class com-
paring to pharmacotherapy [4].
Evolution of approaches to 
the management of non-isch-
emic MR passed through some 
stages, starting from predomi-
nantly MVR to organ-preserving 
approaches like plastic repair [5], 
which are optional methods right 
now. These approaches proved 
their value because numerous 
studies showed that MVRe was 
associated with lower operative 
mortality comparing to MVR [6].
The aim of this study is the 
prospective assessment of the fea-
tures or discrepancies referring 
to the results of surgical manage-
ment of the patients with primary 
mitral regurgitation (MR).
2. Methods
In the prospective single- 
center study are the results of 
treatment among 72 patients with 
primary MR, who were subjected 
to MVR or plastic repair in the 
Department of cardiac surgery affiliated with Lviv regional 
clinical hospital since October, 2013 till February, 2016. Reg-
istration of all parameters was performed 3 times (pre-op, 
early post-op period and in 3 months after the operation) using 
special patient’s visit registration form have been analyzed.
The stages of MR and TR were defined – mild, moderate and 
severe ones. Therefore, a ratio between regurgitation jet area 
and area of left atrium, vena contracta index and PISA method 
have been determined.
Echocardiography was performed before the operation, in 
5–7 days and in 3 months after the operation. Echocardiograph 
Sonos 5500 (Phillips) was used with multifrequency cardiac 
probe (1–2,5 MHz).
Besides ejection fraction 
(EF) measurement using Simp-
son method and Teicholz meth-
od so-called “effective” (Dop-
pler-derived) EF of LV was also 
determined. The essence of this 
method is based upon the fact 
that LV stroke volume (SV) is 
determined with Doppler meth-
od and LV end-diastolic volume 
(EDV) is determined with Te-
icholz method. EF is calculated 
by the formula LV SV/EDV.
Statistical analysis was ac-
complished with an advanced 
analytics software package “Sta-
tistica for Windows 5.0”. Be-
cause the studied groups were 
not equal and parametric vari-
ables distributions were not 
normality (according to Shap-
iro-Wilk’ W test), they were de-
scribed with median (lower-up-
per quartiles). Between-group 
differences were evaluated us-
ing Mann–Whitney U test for 
continuous and ranced variables 
or Fisher’s exact test for cate-
gorical variables. For qualitative 
parameters’ (frequency tables) 
comparison χ2-test was used. 
Difference between parameters 
was significant when р<0,05.
3. Results
Males prevailed in the MVRe 
group – 12 persons (66,67 %), 
female prevailed in the MVR 
group – 29 persons (53,7 %). Age 
median (minimum-maximum) 
was 58 years (19–79 years). 
The most often etiological 
factor of MR were MV degen-
erative changes – 41 patients 
(56,9 %). The most often direct 
cause of MR was chordal ruptu- 
re – 43 cases (59,7 %).
In all patients surgical access 
was performed through median 
sternotomy. After the full hep-
arinization heart-lung machine 
was connected through cannulation of ascending aorta and 
both vena cava separately. Moderate hypothermia (28 ºС) and 
cold potassium-blood cardioplegy were used. Applied approach-
es to the MV were trans-septal one and through the left atrium. 
Plastic repair of MV was done in 18 patients (25 %), MVR 
was performed in 54 patients (75 %).
In the MVRe group before the operation among all patients 
moderate MR was revealed – 19 persons (100 %).
In the MVR group before the operation moderate MR also 
was revealed – 54 patients (100 %).
On the 1st and 2nd control post-op examinations in the 
MVRe group MR was absent among 16 patients (88,89 %), only 
2 patients (11,11 %) had mild MR.
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macotherapy [4].
Evolution of approaches to the management of non-is-
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In the prospective single-center study the results of treatment 
of 72 patients with primary MR (PMR) who were subject-
ed to mitral valve replacement (MVR) or plastic mitral valve 
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recommend MVRe as optional method for MR correction.
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On the 1st and 2nd control post-op examinations in the MVR 
group MR was absent among all 51 patients (100 %).
In the MVR group predominantly two cusps were affect-
ed – 20 patients (35 %), in the MVRe group posterolateral 
cusp was involved – 11 patients (23,5 %).
Plastic repair with usage of annuloplasty ring was per-
formed among 17 patients, plastic repair without annuloplasty 
ring was performed only in 1 patient. Plastic rings produced by 
“Carpentier Edwards” (n=3 [17,6 %]) and “St. Jude” (n=14 [82,4]) 
have been used. Rings’ sizes were 36 mm (n=1 [5,88 %]); 34 mm 
(n=1 [5,88 %]); 32 mm (n=6 [35,29 %]); 30 mm (n=7 [41,18 %]); 
29 mm (n=1 [5,88 %]); 28 mm (n=1 [5,88 %]). For neochords’ 
preparation Gore-Tex and Ethibond have been used.
4 patients, who underwent MVRe, did not yield satisfactory 
result during Hydraulic test, so they immediately were subject-
ed to MVR. During the statistical analysis these patients were 
included into MVR group.
Among the MV prostheses most often ones produced by 
“St. Jude” – 36 cases (70,6 %), “ATS” – 8 patients (15,7 %), 
and other companies (“Medtronic”, “Carbomedics”, “Bjork”) – 
7 patients have been used. In 1 patient bioprosthesis St. Jude 
Epic (29 mm) was implanted. 
Sizes of the used prostheses were 33 mm (n=1 (1,85 %)); 
31 mm (n=1 (1,85 %)); 29 mm (n=20 (38,89)); 27 mm (n=19 
(38,89 %)); 26 mm (n=2 (3,70)); 25 mm (n=8 (14,81 %)).
De Vega tricuspid valve repair was performed among 
60 patients (83,3 %) (1 patient required additional suturing of 
TV cusp), among 12 patients (16,7 %) this approach was not used.
Next concomitant procedures at the time of mitral valve 
repair were performed: 1 coronary artery bypass surgery and 
1 PFO closure.
Signs of chronic heart failure (according to NYHA classifi-
cation) were observed among all 72 pre-op patients.
Among pre-op patients subjected to MVR HF class 2 was 
dominant – 10 patients (55,56 %).
After the intervention on the 1st control examination in 
MVR group 9 patients (50 %) had HF class 1 and 2. 
On the 2nd control examination dominated patients with HF 
class 1 – 14 persons (77,78 %), 2 patients (11,11 %) had HF class 
2 and 2 patients (11,11 %) had HF class 0 according to NYHA.
Among pre-op patients from MVR group dominated HF 
class 3 – 38 persons (70,37 %).
After the operation on the 1st control examination among 
the patients subjected to MVR dominated persons with HF 
class 2 – 40 patients (74,07 %); also 9 patients (16,67 %) had HF 
class 3 and 5 patients (9,26 %) had HF class 1.
After the operation on the 2nd control examination in this 
group of patients 29 persons (56,86 %) had HF class 2, 2 persons 
(3,92 %) had HF class 3 and 20 persons (39,22 %) had HF class 1.
Positive trend referring to restoration of normal cardiac 
rhythm after the surgical intervention was observed only among 
the patients subjected to MVRe: 14 pre-op persons (77,78 %) and 
16 persons (88,89 %) on the 1st and 2nd pos-op examination had 
sinus rhythm.
Negative trend referring to restoration of normal cardiac 
rhythm after the surgical intervention was observed in the 
group of patients exposed to MVR: 32 pre-op patients (59,26 %), 
31 patients (57,42 %) on the 1st post op examination and 29 pa-
tients (56,86 %) on the 2nd post-op one had sinus rhythm.
Absolute majority of pre-op patients had left ventricular 
dilatation (LVD), increase of LV and RV end-diastolic volume 
(EDV) and significant increase of pulmonary artery (PA) systol-
ic pressure. These parameters clearly diminished in several days 
after the operation and such a dynamics for some indices (size of 
right atrium [RA], RV plus PA systolic pressure) and statistically 
significant improvement of mentioned above echocardiographic 
post op parameters persisted up to 2nd post op examination that 
testifies about positive remodeling after surgery.
EF measured with Simpson method and Teicholz method 
has decreased in the early post-op period and subsequently 
did not significantly change; some increase of EF measured 
with Simpson method on the 3rd examination comparing to 
the 2nd one have been noted. In contrast, the pre-op effective 
(Doppler-derived) EF was significantly decreased comparing to 
normal parameters, clearly has increased in the early post op pe-
riod and has been reliably increasing up to the 3rd examination.
In the MVR group one complication (acute dynamic ileus) 
occurred that required laparotomy and small intestine’s decom-
pression.
In the MVR next complications were observed: pericardial 
drainage (1 patient); two successive pericardial drainages (1 pa-
tient); axillary artery embolism with subsequent thrombectomy 
(1 patient); acute ischemic stroke (1 patient).
In the MVR group after the operation 3 persons died: one 
female patient died on the 60th day after the surgery (infec-
tious endocarditis with embologenic vegetations of the MV 
posterolateral cusp and abscess of the LV posterior wall) due to 
polyorganic (in particular, renal) insufficiency; one male patient 
(pre-op infectious endocarditis with vegetations and perfora-
tion of MV anteromedial cusp); one male patient died due to 
sudden cardiac arrest with subsequent failed cardiopulmonary 
resuscitation.
In the group of patients subjected to MVRe due to primary 
MR during in-patient department stay and next two control 
visits no lethal cases were revealed.
4. Discussion
MVRe comparing to MVR yields better results and among 
patients with severe organic MR diminished mortality down 
to 70%. These results stress the importance of early detection, 
assessment and management of MR [2].
Long-term studies showed that comparing to medical treat-
ment early surgical intervention on MV among patients with 
prolapse of cusps was associated with significantly lower risk 
of the future death due to cardiac causes or HF and longer life 
expectancy [4].
Echocardiographic methods of MR allow to specify the 
timely indications for surgical intervention during repeated ex-
aminations aimed at regurgitation’s stage assessment [7].
In the study conducted by James et al. [8] it was proved, 
that during 8 years among 58370 patients subjected to isolated 
primary operations on MV due to MR (n=47,126) prevalence 
of MVRe comparing to MVR increased from 51 % to 69 % 
(p<0.0001). Among the patients from MVR group (n=24,404) 
evident decrease of mechanic prostheses’ usage was observed: 
from 68 % to 37 % (p<0.0001). Surgical mortality in MVR group 
was significantly higher comparing to MVRe (3.8 % versus 
1.4 %, p<0.0001) that corresponds to this study results. Among 
the patients subjected to selective isolated MVRe (n=28,140) 
surgical mortality was 1,2 %. For non-symptomatic (class І) 
patients surgical mortality was 0,6 %.
By Catherine M. Otto [6] it was confirmed that surgical 
mortality is lower in MVRe comparing to MVR (2–4 % versus 
5–10 %). Among the patients with MV prolapse remote clinical 
outcomes were wonderful, survival rate was 80 and 94 % during 
the next 5 and 10 years in MVRe group comparing to 40 and 
60 % in MVR group. There trends correspond to the results of 
this study, characterized by lower mortality in MVRe group.
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Gillinov et al. noted, that in 10 years after the MVRe reop-
eration absence rate was 93 %. Among 30 patients, who required 
reoperations due to late valvular dysfunction, repair was unsuc-
cessful in 16 persons (53 %) owing to progressive degenerative 
disease [3]. Independent (as the single method) chordal shorten-
ing, annuloplasty and resection of cusps without annuloplasty 
jeopardized positive remote results of surgical management.
Interestingly, according to some studies [9] surgical inter-
vention was denied for 49 % patients with severe symptomatic 
MR. Diminution of LV EF, old age, comorbid conditions were 
the basic striking features of the patients who were denied. Im-
portance of age and LV EF referring to patients’ operability are 
still discussible. 
Negative dynamics concerning restoration of sinus rhythm 
among the patients subjected to MVR probably may be ex-
plained by more severe preceding pre-op state, more prolonged 
medical history and consequently larger size of LA and pro-
longed medical history of atrial fibrillation. These factors are 
known negative predictors of preservation and restoration of 
sinus rhythm after the surgical correction of MR. Along with 
MV correction these patients were not exposed to simultaneous 
open-surgery isolation of pulmonary veins, ablation of caval-tri-
cuspid isthmus and areas of possible arrhythmias expansion on 
the basis of MV. Open ablation in atrial fibrillation improves 
post op outcome referring preservation of sinus rhythm and 
non-recurrence period’s duration [10].
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